Kingsin Completes Construction of Production and Assembly Cleanrooms, Entering Pilot Manufacturing Phase

In the first quarter of 2025, Kingsin Life Science Technology Co., Ltd. successfully completed the construction of its production cleanrooms and assembly cleanrooms, which have now officially entered the pilot manufacturing stage. The commissioning of these controlled environments marks a significant milestone in enhancing Kingsin’s capabilities for high-quality medical device manufacturing.

As part of our core business, we provide one-stop manufacturing solutions with engineering support and regulatory compliant lab services, all within facilities designed to meet international cleanliness standards. Trial production is currently underway, with process optimization and quality refinement progressing steadily.

Kingsin remains committed to its mission: “Provide safe, reliable, and regulatory-compliant biomedical products to the world,” as we continue to advance toward cleaner, smarter, and more dependable medical production systems.